AIF1 and central nervous system cancer: Compared with the control group, the expression of M2-like marker ARG1 and total TAM marker IBA1 were both upregulated in glioma allografts co-implanted with GL261-LRIG3 and TAM-shNETO2 (Fig. 5g).